id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0129-0014,FDA,FDA-2012-N-0129,Agency Information Collection Activities; Proposed Additional Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants,Notice,60 Day Proposed Information Collection,2019-11-22T05:00:00Z,2019,11,2019-11-22T05:00:00Z,2020-01-22T04:59:59Z,2019-11-22T14:28:29Z,2019-25328,0,0,0900006484197e92
FDA-2012-N-0129-0015,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2019-11-22T05:00:00Z,2019,11,2019-11-22T05:00:00Z,,2019-11-22T16:45:10Z,2019-07467,0,0,0900006483bad4d0
FDA-2012-N-0129-0013,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; General Licensing
Provisions; Section 351(k) Biosimilar Applications",Notice,30 Day Proposed Information Collection,2018-11-20T05:00:00Z,2018,11,2018-11-20T05:00:00Z,2018-12-21T04:59:59Z,2018-11-20T14:24:41Z,2018-25232,0,0,09000064838ec50e
FDA-2012-N-0129-0012,FDA,FDA-2012-N-0129,Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar  Applications,Notice,60 Day Proposed Information Collection,2018-07-03T04:00:00Z,2018,7,2018-07-03T04:00:00Z,2018-09-05T03:59:59Z,2018-07-03T13:13:34Z,2018-14265,0,0,09000064834948fb
FDA-2012-N-0129-0011,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; General Licensing Provisions; Section 351(k) Biosimilar Applications",Notice,Notice of Approval,2016-02-02T05:00:00Z,2016,2,2016-02-02T05:00:00Z,,2016-02-02T20:22:59Z,2016-01783,0,0,0900006481e44e4f
FDA-2012-N-0129-0010,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; General Licensing
Provisions; Section 351(k) Biosimilar Applications",Notice,30 Day Proposed Information Collection,2015-07-01T04:00:00Z,2015,7,2015-07-01T04:00:00Z,2015-08-01T03:59:59Z,2015-07-01T14:17:59Z,2015-16128,0,0,0900006481b61af0
FDA-2012-N-0129-0006,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Proposed Collection;
Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications",Notice,60 Day Proposed Information Collection,2015-02-03T05:00:00Z,2015,2,2015-02-03T05:00:00Z,2015-04-07T03:59:59Z,2015-04-23T02:01:59Z,2015-02025,0,0,09000064819ef83e
FDA-2012-N-0129-0005,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Submissions for Office of Management and Budget Review, Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications",Notice,30 Day Proposed Information Collection,2012-05-24T04:00:00Z,2012,5,2012-05-24T04:00:00Z,2012-06-26T03:59:59Z,2015-01-21T17:13:12Z,2012-12591,0,0,090000648101b461
FDA-2012-N-0129-0002,FDA,FDA-2012-N-0129,Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Correction,Notice,Correction,2012-02-23T05:00:00Z,2012,2,2012-02-23T05:00:00Z,,2015-01-21T17:11:14Z,2012-04168,0,0,0900006480fbeaab
FDA-2012-N-0129-0001,FDA,FDA-2012-N-0129,Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications,Notice,60 Day Proposed Information Collection,2012-02-15T05:00:00Z,2012,2,2012-02-15T05:00:00Z,2012-04-17T03:59:59Z,2015-01-21T17:10:49Z,2012-03548,0,0,0900006480fb7292